BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, Nicolao F, Angeloni S, Masini A, Ridola L, Attili AF, Merli M. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42:1158-1165. [PMID: 16250033 DOI: 10.1002/hep.20905] [Cited by in Crossref: 109] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Nardelli S, Riggio O, Turco L, Gioia S, Puzzono M, Bianchini M, Ridola L, Aprile F, Gitto S, Pelle G, Di Martino M, Marzocchi G, Caporali C, Spagnoli A, Di Rocco A, Schepis F. Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis. Radiology 2021;299:133-40. [PMID: 33529134 DOI: 10.1148/radiol.2021203051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Riggio O, Ridola L. Emerging drugs for hepatic encephalopathy. Expert Opin Emerg Drugs 2009;14:537-49. [PMID: 19552607 DOI: 10.1517/14728210903055067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
5 Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31:537-547. [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 120] [Article Influence: 13.6] [Reference Citation Analysis]
6 Yi F, Guo X, Wang L, Xu X, An Y, Tang Y, Zhang W, Tacke F, Arora A, Qi X. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis. J Gastroenterol Hepatol 2021;36:1694-702. [PMID: 33393106 DOI: 10.1111/jgh.15386] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Blei AT. Portal hypertension and its complications: . Current Opinion in Gastroenterology 2007;23:275-82. [DOI: 10.1097/mog.0b013e3280b0841f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
8 Elwir S, Hal H, Veith J, Schreibman I, Kadry Z, Riley T. Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy. Gastroenterol Rep (Oxf) 2016;4:221-5. [PMID: 26463277 DOI: 10.1093/gastro/gov049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Weissenborn K. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs. 2019;79:5-9. [PMID: 30706420 DOI: 10.1007/s40265-018-1018-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
10 Amodio P. Hepatic encephalopathy: Diagnosis and management. Liver Int. 2018;38:966-975. [PMID: 29624860 DOI: 10.1111/liv.13752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
11 Tarantino G, Citro V, Conca P, Riccio A, Tarantino M, Capone D, Cirillo M, Lobello R, Iaccarino V. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 2009;9:89. [PMID: 19930687 DOI: 10.1186/1471-230x-9-89] [Cited by in Crossref: 64] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
12 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther. 2010;1:54-63. [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
13 Shreve L, Lee EW. Role of Interventional Radiology in Complications of Portal Hypertension. Journal of Clinical Gastroenterology 2019;53:342-9. [DOI: 10.1097/mcg.0000000000001180] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Odeh M. Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-? theory. Eur J Clin Invest 2007;37:291-304. [DOI: 10.1111/j.1365-2362.2007.01778.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
15 Privitera G, Figorilli F, Jalan R, Mehta G. Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series. Gastroenterology 2018;155:1649-50. [DOI: 10.1053/j.gastro.2018.06.092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Romero-Gómez M. Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert Opin Pharmacother. 2010;11:1317-1327. [PMID: 20384539 DOI: 10.1517/14656561003724721] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
17 Leng X, Zhang F, Zhang M, Guo H, Yin X, Xiao J, Wang Y, Zou X, Zhuge Y. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt. Eur J Gastroenterol Hepatol 2019;31:853-8. [PMID: 30633039 DOI: 10.1097/MEG.0000000000001349] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
18 Saad WE. Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy. Semin Intervent Radiol 2014;31:262-5. [PMID: 25177088 DOI: 10.1055/s-0034-1382795] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
19 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006;22:254-262. [PMID: 16550040 DOI: 10.1097/01.mog.0000218962.93806.9a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
20 Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M, Jalan R, Brookes J, Thalassinos E, Burroughs AK, Cordoba J, Nevens F; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448-2457. [PMID: 23401201 DOI: 10.1002/hep.26314] [Cited by in Crossref: 143] [Cited by in F6Publishing: 91] [Article Influence: 17.9] [Reference Citation Analysis]
21 White H. Neurologic manifestations of acute and chronic liver disease. Continuum (Minneap Minn). 2014;20:670-680. [PMID: 24893241 DOI: 10.1212/01.con.0000450973.84075.a7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Loggini A, Martinez RC, Kramer CL. Cerebral Herniation from Hyperammonemic Cerebral Edema: A Potentially Reversible Neurological Emergency. Neurocrit Care 2019;30:681-5. [DOI: 10.1007/s12028-018-0578-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Qi X, Qi X, Zhang Y, Shao X, Wu C, Wang Y, Wang R, Zhang X, Deng H, Hou F, Li J, Guo X. Prevalence and Clinical Characteristics of Spontaneous Splenorenal Shunt in Liver Cirrhosis: A Retrospective Observational Study Based on Contrast-Enhanced Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) Scans. Med Sci Monit 2017;23:2527-34. [PMID: 28542116 DOI: 10.12659/msm.901656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
24 Gamal M, Abdel Wahab Z, Eshra M, Rashed L, Sharawy N. Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy. Neurol Res Int. 2014;2014:254683. [PMID: 24693424 DOI: 10.1155/2014/254683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54:1030-1040. [PMID: 21145874 DOI: 10.1016/j.jhep.2010.11.015] [Cited by in Crossref: 143] [Cited by in F6Publishing: 110] [Article Influence: 13.0] [Reference Citation Analysis]
26 Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, Mcwilliams JP, Dinorcia J, Padia SA, Kee ST. Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy. American Journal of Gastroenterology 2018;113:1187-96. [DOI: 10.1038/s41395-018-0109-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33:739-747. [PMID: 21306407 DOI: 10.1111/j.1365-2036.2011.04590.x] [Cited by in Crossref: 216] [Cited by in F6Publishing: 169] [Article Influence: 21.6] [Reference Citation Analysis]
28 Riggio O, Amodio P, Farcomeni A, Merli M, Nardelli S, Pasquale C, Pentassuglio I, Gioia S, Onori E, Piazza N. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2015;13:1346-1352. [PMID: 25572976 DOI: 10.1016/j.cgh.2014.12.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
29 Sahney A, Sharma BC, Jindal A, Anand L, Arora V, Vijayaraghavan R, Dhamija RM, Kumar G, Bhardwaj A, Sarin SK. A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism. Liver Int. 2019;39:684-693. [PMID: 30554466 DOI: 10.1111/liv.14024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc 2014;89:241-53. [PMID: 24411831 DOI: 10.1016/j.mayocp.2013.11.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 9.1] [Reference Citation Analysis]
31 Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A, Milan G, Tripodi FS, Cirillo M, Lobello R. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009;9:21. [PMID: 19292923 DOI: 10.1186/1471-230x-9-21] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
32 Ridola L, Riggio O, Gioia S, Faccioli J, Nardelli S. Clinical management of type C hepatic encephalopathy. United European Gastroenterol J 2020;8:536-43. [PMID: 32213035 DOI: 10.1177/2050640620909675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
33 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
34 De Rui M, Schiff S, Aprile D, Angeli P, Bombonato G, Bolognesi M, Sacerdoti D, Gatta A, Merkel C, Amodio P, Montagnese S. Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking. Metab Brain Dis 2013;28:245-8. [PMID: 23180317 DOI: 10.1007/s11011-012-9360-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
35 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
36 Choudhary NS, Baijal SS, Saigal S, Agarwal A, Saraf N, Khandelwal R, Jain V, Khandelwal AH, Kapoor A, Jain D, Misra SR, Puri R, Sud R, Soin AS. Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy. J Clin Exp Hepatol 2017;7:300-4. [PMID: 29234193 DOI: 10.1016/j.jceh.2017.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
37 Frenette CT, Levy C, Saab S. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Dig Dis Sci 2021. [PMID: 34169435 DOI: 10.1007/s10620-021-07075-2] [Reference Citation Analysis]
38 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
39 Ridola L, Riggio O. Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic. J Clin Med 2021;10:298. [PMID: 33467479 DOI: 10.3390/jcm10020298] [Reference Citation Analysis]
40 Borentain P, Soussan J, Resseguier N, Botta-Fridlund D, Dufour JC, Gérolami R, Vidal V. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagn Interv Imaging 2016;97:643-50. [PMID: 26947721 DOI: 10.1016/j.diii.2016.02.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
41 An J, Kim KW, Han S, Lee J, Lim YS. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39:1418-1426. [PMID: 24754260 DOI: 10.1111/apt.12771] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
42 Riggio O, Nardelli S, Gioia S, Lucidi C, Merli M. Management of hepatic encephalopathy as an inpatient. Clin Liver Dis (Hoboken) 2015;5:79-82. [PMID: 31040956 DOI: 10.1002/cld.457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 He C, Lv Y, Wang Z, Guo W, Tie J, Li K, Niu J, Zuo L, Yu T, Yuan X, Chen H, Wang Q, Liu H, Bai W, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Wang J, Yin Z, Fan D, Han G. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis. Digestive and Liver Disease 2018;50:1315-23. [DOI: 10.1016/j.dld.2018.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
44 Philips CA, Rajesh S, Augustine P, Padsalgi G, Ahamed R. Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options. Hepat Med. 2019;11:23-34. [PMID: 30774483 DOI: 10.2147/hmer.s169024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
45 Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology. 2008;135:1582-1590. [PMID: 18647604 DOI: 10.1053/j.gastro.2008.06.043] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
46 Philips CA, Kumar L, Augustine P. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala. Indian J Gastroenterol. 2017;36:411-419. [PMID: 29124669 DOI: 10.1007/s12664-017-0787-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Pantham G, Post A, Venkat D, Einstadter D, Mullen KD. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Dig Dis Sci 2017;62:2166-73. [DOI: 10.1007/s10620-017-4630-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
48 Lo GH. The Transplantation of Fecal Microbiota for Cirrhotic Patients. Gastroenterology 2019;157:902. [PMID: 31306634 DOI: 10.1053/j.gastro.2019.06.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Thornton JG, Mullen KD. The role of hepatic encephalopathy in the era of MELD. Liver Transpl 2007;13:1364-5. [DOI: 10.1002/lt.21229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
50 Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2009;104:885-90. [PMID: 19293781 DOI: 10.1038/ajg.2009.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
51 Praktiknjo M, Simón-talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-gonzález J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genescà J, Trebicka J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Stangl F. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Journal of Hepatology 2020;72:1140-50. [DOI: 10.1016/j.jhep.2019.12.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 32.0] [Reference Citation Analysis]
52 Intagliata NM, Saad WE, Caldwell SH. Effects of restoring portal flow with anticoagulation and partial splenorenal shunt embolization. Hepatology. 2015;61:1088-1090. [PMID: 24867875 DOI: 10.1002/hep.27241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626. [PMID: 19707277 DOI: 10.2147/tcrm.s4443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
54 Qi X, Ye C, Hou Y, Guo X. A large spontaneous intrahepatic portosystemic shunt in a cirrhotic patient. Intractable Rare Dis Res. 2016;5:58-60. [PMID: 26989653 DOI: 10.5582/irdr.2016.01000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
55 Guillaume M, Bureau C. Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome? Gastroenterology 2018;154:1569-71. [DOI: 10.1053/j.gastro.2018.03.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
56 Bai M, Qi XS, Yang ZP, Wu KC, Fan DM, Han GH. EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis. World J Gastrointest Pharmacol Ther 2014;5:97-104. [PMID: 24868490 DOI: 10.4292/wjgpt.v5.i2.97] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
57 Krishnamurthy P, Ahmad A. Successful treatment of recurrent hepatic encephalopathy with revision of transjugular intrahepatic portasystemic shunt and embolisation of splenorenal shunt. BMJ Case Rep 2021;14:e242368. [PMID: 34167979 DOI: 10.1136/bcr-2021-242368] [Reference Citation Analysis]
58 Lynn AM, Singh S, Congly SE, Khemani D, Johnson DH, Wiesner RH, Kamath PS, Andrews JC, Leise MD. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy. Liver Transpl 2016;22:723-31. [PMID: 26970243 DOI: 10.1002/lt.24440] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 9.8] [Reference Citation Analysis]
59 Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Nogas Sobrinho S, Pentassuglio I, Greco F, De Santis A, Merli M, Riggio O. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. Digestive and Liver Disease 2016;48:1072-7. [DOI: 10.1016/j.dld.2016.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
60 Gana JC, Serrano CA, Ling SC. Angiogenesis and portal-systemic collaterals in portal hypertension. Ann Hepatol. 2016;15:303-313. [PMID: 27049484 DOI: 10.5604/16652681.1198799] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
61 Avraham Y, Grigoriadis N, Poutahidis T, Vorobiev L, Magen I, Ilan Y, Mechoulam R, Berry E. Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol. 2011;162:1650-1658. [PMID: 21182490 DOI: 10.1111/j.1476-5381.2010.01179.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
62 Nardelli S, Gioia S, Ridola L, Riggio O. Radiological Intervention for Shunt Related Encephalopathy. J Clin Exp Hepatol 2018;8:452-9. [PMID: 30564003 DOI: 10.1016/j.jceh.2018.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
63 Montagnese S, Amato E, Schiff S, Facchini S, Angeli P, Gatta A, Amodio P. A patients’ and caregivers’ perspective on hepatic encephalopathy. Metab Brain Dis 2012;27:567-72. [DOI: 10.1007/s11011-012-9325-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
64 Acharya C, Bajaj JS. Current Management of Hepatic Encephalopathy. Am J Gastroenterol. 2018;113:1600-1612. [PMID: 30002466 DOI: 10.1038/s41395-018-0179-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
65 Nishida S, Hamada K, Nishino N, Fukushima D, Koyanagi R, Horikawa Y, Shiwa Y, Saitoh S. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese. World J Hepatol 2019;11:531-41. [PMID: 31293721 DOI: 10.4254/wjh.v11.i6.531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
66 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
67 Cacciapaglia F, Vadacca M, Coppolino G, Buzzulini F, Rigon A, Zennaro D, Zardi E, Afeltra A. Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported. Lupus. 2007;16:56-58. [PMID: 17283587 DOI: 10.1177/0961203306072390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
68 Cui J, Smolinski SE, Liu F, Xu D, Dulaimy K, Irani Z. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience. AJR Am J Roentgenol. 2018;210:438-446. [PMID: 29261352 DOI: 10.2214/ajr.17.18222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Foster KJ, Lin S, Turck CJ. Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am. 2010;22:341-350. [PMID: 20691385 DOI: 10.1016/j.ccell.2010.04.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
70 Frederick RT. Extent of reversibility of hepatic encephalopathy following liver transplantation. Clin Liver Dis 2012;16:147-58. [PMID: 22321470 DOI: 10.1016/j.cld.2011.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
71 Pereira K, Carrion AF, Salsamendi J, Doshi M, Baker R, Kably I. Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm. Cardiovasc Intervent Radiol 2016;39:170-82. [DOI: 10.1007/s00270-015-1197-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
72 Seman M, Scatton O, Zalinski S, Chrissostalis A, Legmann P, Soubrane O. Laparoscopic division of a portosystemic shunt to treat chronic hepatic encephalopathy. HPB (Oxford) 2008;10:211-3. [PMID: 18773056 DOI: 10.1080/13651820802007456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L. Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects. World J Gastroenterol 2020;26:1726-32. [PMID: 32351289 DOI: 10.3748/wjg.v26.i15.1726] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
74 Rodriguez EA, Perez R, Zhang N, Lim ES, Miller C, Schwartz MA, McGirr AJ, Srinivasan A, Hewitt W, Silva AC, Rakela J, Vargas HE. Clinical Outcomes of Portosystemic Shunts on the Short-Term Outcome of Liver Transplantation. Liver Transpl. 2019;. [PMID: 31872966 DOI: 10.1002/lt.25710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
75 Simón-talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Rönsch M, Stoevesandt D, Carrion L, Botella ER. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology 2018;154:1694-1705.e4. [DOI: 10.1053/j.gastro.2018.01.028] [Cited by in Crossref: 66] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
76 Elwir S, Rahimi RS. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. J Clin Transl Hepatol. 2017;5:142-151. [PMID: 28660152 DOI: 10.14218/jcth.2016.00069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
77 Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Maeda M, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I. Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration. Hepatol Res 2018;48:1020-30. [PMID: 29882396 DOI: 10.1111/hepr.13199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
78 Zhang H, Xiao J, Tu J, Zhang M, Zhang F, Yin Q, Zhuge Y. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment. Eur J Gastroenterol Hepatol 2021;33:752-61. [PMID: 33731589 DOI: 10.1097/MEG.0000000000002079] [Reference Citation Analysis]
79 Nardelli S, Ridola L, Gioia S, Riggio O. Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments. Curr Treat Options Gastro 2018;16:253-9. [DOI: 10.1007/s11938-018-0183-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]